mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress

Naomi X Y Ling1, Adrian Kaczmarek2, Ashfaqul Hoque1

  • 1Metabolic Signalling Laboratory, St Vincent's Institute of Medical Research, School of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

Nature Metabolism
|January 30, 2020
PubMed

Insights

Mammalian target of rapamycin (mTOR) complex 1 (TORC1) directly inhibits AMP-activated protein kinase (AMPK) signaling. This reciprocal regulation impacts cell proliferation and offers new cancer treatment strategies targeting nutrient-poor tumors.

Area of Science:

  • Cellular Metabolism
  • Molecular Biology
  • Signal Transduction

Background:

  • Mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways are crucial for cellular metabolism and proliferation.
  • Dysregulation of these pathways is linked to diseases like cancer and type 2 diabetes.
  • AMPK signaling typically reduces cell proliferation, partly by inhibiting TOR complex-1 (TORC1).

Purpose of the Study:

  • To investigate the regulatory relationship between TORC1 and AMPK signaling.
  • To identify the molecular mechanisms underlying this interaction.
  • To explore therapeutic opportunities based on this bidirectional regulation.

Main Methods:

  • Investigated TORC1's effect on AMPK signaling in yeast and mammalian cells.
  • Utilized genetic and pharmacological inhibition of TORC1.
  • Analyzed phosphorylation sites, including Ser367 in yeast and Ser347/345 in mammalian AMPK, and Thr172 in the activation loop.

Main Results:

  • Demonstrated that TORC1 directly down-regulates AMPK signaling via phosphorylation of conserved residues.
  • Observed reduced AMPK activation loop phosphorylation (Thr172) upon TORC1 inhibition.
  • Showed TORC1 inhibition activates AMPK independently of AMP:ATP ratios, leading to growth limitation under nutrient stress.

Conclusions:

  • Revealed a fundamental, bidirectional regulatory mechanism between mTOR and AMPK signaling networks.
  • Identified a novel pathway for TORC1 to control AMPK activity.
  • Uncovered potential therapeutic strategies targeting the tumor microenvironment by modulating these pathways for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K